| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 6.65e-13 | 26 | 57 | 7 | GO:0005248 | |
| GeneOntologyMolecularFunction | sodium channel activity | 1.28e-10 | 52 | 57 | 7 | GO:0005272 | |
| GeneOntologyMolecularFunction | sodium ion binding | 3.11e-10 | 14 | 57 | 5 | GO:0031402 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A TMEM37 TMC8 ANO7 CATSPER3 PKD1L3 | 5.23e-09 | 459 | 57 | 12 | GO:0005216 |
| GeneOntologyMolecularFunction | alkali metal ion binding | 9.95e-09 | 26 | 57 | 5 | GO:0031420 | |
| GeneOntologyMolecularFunction | channel activity | SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A TMEM37 TMC8 ANO7 CATSPER3 PKD1L3 | 2.32e-08 | 525 | 57 | 12 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A TMEM37 TMC8 ANO7 CATSPER3 PKD1L3 | 2.37e-08 | 526 | 57 | 12 | GO:0022803 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A TMEM37 CATSPER3 PKD1L3 | 4.14e-08 | 343 | 57 | 10 | GO:0005261 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ABCA13 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A TMEM37 TMC8 SLC19A3 ANO7 CATSPER3 PKD1L3 SLC7A11 ABCA7 | 1.16e-07 | 1180 | 57 | 16 | GO:0022857 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR2C1 OR4K17 HTR6 OR1I1 OR7C1 FPR2 OR2G3 OR1A1 GPR152 OR1E1 OR1E2 OR7G2 GNRHR S1PR4 | 1.31e-07 | 884 | 57 | 14 | GO:0004930 |
| GeneOntologyMolecularFunction | transporter activity | ABCA13 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A TMEM37 TMC8 SLC19A3 ANO7 CATSPER3 PKD1L3 SLC7A11 ABCA7 | 3.85e-07 | 1289 | 57 | 16 | GO:0005215 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 5.51e-07 | 171 | 57 | 7 | GO:0015081 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A TMEM37 CATSPER3 PKD1L3 | 6.90e-07 | 465 | 57 | 10 | GO:0046873 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR2C1 OR4K17 HTR6 OR1I1 OR7C1 FPR2 OR2G3 OR1A1 GPR152 OR1E1 OR1E2 PKD1L3 OR7G2 ABCA7 GNRHR S1PR4 | 7.36e-07 | 1353 | 57 | 16 | GO:0004888 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A TMEM37 TMC8 ANO7 CATSPER3 PKD1L3 | 1.93e-06 | 793 | 57 | 12 | GO:0015075 |
| GeneOntologyMolecularFunction | olfactory receptor activity | 3.36e-06 | 431 | 57 | 9 | GO:0004984 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A TMEM37 ANO7 CATSPER3 PKD1L3 | 8.21e-06 | 758 | 57 | 11 | GO:0015318 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A TMEM37 CATSPER3 PKD1L3 | 9.89e-06 | 627 | 57 | 10 | GO:0022890 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A TMEM37 CATSPER3 PKD1L3 | 1.63e-05 | 664 | 57 | 10 | GO:0008324 |
| GeneOntologyMolecularFunction | UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity | 2.40e-05 | 3 | 57 | 2 | GO:0008489 | |
| GeneOntologyMolecularFunction | gated channel activity | 3.71e-04 | 334 | 57 | 6 | GO:0022836 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 1.06e-03 | 17 | 57 | 2 | GO:0099508 | |
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | 1.74e-03 | 180 | 57 | 4 | GO:0004866 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 1.81e-03 | 182 | 57 | 4 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 1.88e-03 | 184 | 57 | 4 | GO:0022832 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | 2.00e-03 | 187 | 57 | 4 | GO:0030414 | |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | 2.60e-03 | 201 | 57 | 4 | GO:0061135 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase inhibitor activity | 3.36e-03 | 105 | 57 | 3 | GO:0004867 | |
| GeneOntologyMolecularFunction | UDP-galactosyltransferase activity | 3.76e-03 | 32 | 57 | 2 | GO:0035250 | |
| GeneOntologyMolecularFunction | modified amino acid transmembrane transporter activity | 3.99e-03 | 33 | 57 | 2 | GO:0072349 | |
| GeneOntologyMolecularFunction | galactosyltransferase activity | 4.48e-03 | 35 | 57 | 2 | GO:0008378 | |
| GeneOntologyMolecularFunction | calcium channel activity | 5.98e-03 | 129 | 57 | 3 | GO:0005262 | |
| GeneOntologyMolecularFunction | peptidase regulator activity | 6.21e-03 | 257 | 57 | 4 | GO:0061134 | |
| GeneOntologyMolecularFunction | enzyme inhibitor activity | 7.93e-03 | 435 | 57 | 5 | GO:0004857 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 8.64e-03 | 49 | 57 | 2 | GO:0140359 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 9.21e-03 | 151 | 57 | 3 | GO:0015085 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 9.33e-03 | 51 | 57 | 2 | GO:0140303 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 9.54e-03 | 153 | 57 | 3 | GO:0008194 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 6.59e-12 | 36 | 57 | 7 | GO:0086010 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 3.67e-10 | 62 | 57 | 7 | GO:0086002 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 4.13e-10 | 63 | 57 | 7 | GO:0019228 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 4.14e-09 | 87 | 57 | 7 | GO:0086001 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 6.63e-09 | 93 | 57 | 7 | GO:0086003 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 2.43e-08 | 112 | 57 | 7 | GO:0019226 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 4.16e-08 | 121 | 57 | 7 | GO:0051899 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR2C1 OR4K17 OR1I1 OR7C1 SCN1A OR2G3 OR1A1 SCN9A OR1E1 OR1E2 PKD1L3 OR7G2 | 5.05e-08 | 582 | 57 | 12 | GO:0050906 |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 5.82e-08 | 127 | 57 | 7 | GO:0070252 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 2.09e-07 | 153 | 57 | 7 | GO:0030048 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 3.78e-07 | 167 | 57 | 7 | GO:0060048 | |
| GeneOntologyBiologicalProcess | detection of stimulus | OR2C1 OR4K17 OR1I1 OR7C1 SCN1A OR2G3 OR1A1 SCN9A OR1E1 OR1E2 PKD1L3 OR7G2 | 5.15e-07 | 722 | 57 | 12 | GO:0051606 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR2C1 OR4K17 HTR6 OR1I1 OR7C1 FPR2 OR2G3 OR1A1 GPR152 OR1E1 OR1E2 TAC3 OR7G2 DAGLA GNRHR S1PR4 | 7.20e-07 | 1395 | 57 | 16 | GO:0007186 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR2C1 OR4K17 OR1I1 OR7C1 OR2G3 OR1A1 OR1E1 OR1E2 PKD1L3 OR7G2 | 7.56e-07 | 485 | 57 | 10 | GO:0050907 |
| GeneOntologyBiologicalProcess | sodium ion transport | 8.47e-07 | 275 | 57 | 8 | GO:0006814 | |
| GeneOntologyBiologicalProcess | sensory perception | OR2C1 OR4K17 OR1I1 OR7C1 SCN1A OR2G3 SCN8A OR1A1 SCN9A OR1E1 OR1E2 CLN6 PKD1L3 OR7G2 | 9.10e-07 | 1072 | 57 | 14 | GO:0007600 |
| GeneOntologyBiologicalProcess | action potential | 1.32e-06 | 201 | 57 | 7 | GO:0001508 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR2C1 OR4K17 OR1I1 OR7C1 OR2G3 OR1A1 OR1E1 OR1E2 PKD1L3 OR7G2 | 1.52e-06 | 524 | 57 | 10 | GO:0009593 |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 1.65e-06 | 208 | 57 | 7 | GO:0035725 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 2.19e-06 | 217 | 57 | 7 | GO:0006941 | |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR2C1 OR4K17 OR1I1 OR7C1 OR2G3 OR1A1 OR1E1 OR1E2 PKD1L3 OR7G2 | 2.23e-06 | 547 | 57 | 10 | GO:0007606 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | 2.64e-06 | 432 | 57 | 9 | GO:0050911 | |
| GeneOntologyBiologicalProcess | sensory perception of smell | 4.80e-06 | 465 | 57 | 9 | GO:0007608 | |
| GeneOntologyBiologicalProcess | heart contraction | 1.74e-05 | 298 | 57 | 7 | GO:0060047 | |
| GeneOntologyBiologicalProcess | heart process | 2.20e-05 | 309 | 57 | 7 | GO:0003015 | |
| GeneOntologyBiologicalProcess | regulation of glutathione biosynthetic process | 2.25e-05 | 3 | 57 | 2 | GO:1903786 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A TMEM37 TMC8 ANO7 CATSPER3 PKD1L3 | 4.33e-05 | 1115 | 57 | 12 | GO:0034220 |
| GeneOntologyBiologicalProcess | ganglioside metabolic process | 6.95e-05 | 29 | 57 | 3 | GO:0001573 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A TMEM37 ANO7 CATSPER3 PKD1L3 | 9.08e-05 | 1017 | 57 | 11 | GO:0098660 |
| GeneOntologyBiologicalProcess | ganglioside biosynthetic process via lactosylceramide | 1.12e-04 | 6 | 57 | 2 | GO:0010706 | |
| GeneOntologyBiologicalProcess | muscle contraction | 1.12e-04 | 400 | 57 | 7 | GO:0006936 | |
| GeneOntologyBiologicalProcess | behavior | PTCHD1 HTR6 SCN1A SCN2A SCN3A SCN8A SCN9A CLN6 SLC7A11 ABCA7 | 1.47e-04 | 891 | 57 | 10 | GO:0007610 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A TMEM37 CATSPER3 PKD1L3 | 1.94e-04 | 922 | 57 | 10 | GO:0098662 |
| GeneOntologyBiologicalProcess | negative regulation of ferroptosis | 2.08e-04 | 8 | 57 | 2 | GO:0110076 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A TMEM37 CATSPER3 PKD1L3 | 2.30e-04 | 942 | 57 | 10 | GO:0098655 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A TMEM37 TMC8 ANO7 CATSPER3 PKD1L3 | 3.12e-04 | 1374 | 57 | 12 | GO:0006811 |
| GeneOntologyBiologicalProcess | ferroptosis | 3.33e-04 | 10 | 57 | 2 | GO:0097707 | |
| GeneOntologyBiologicalProcess | regulation of ferroptosis | 3.33e-04 | 10 | 57 | 2 | GO:0110075 | |
| GeneOntologyBiologicalProcess | metal ion transport | SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A TMEM37 CATSPER3 PKD1L3 | 3.71e-04 | 1000 | 57 | 10 | GO:0030001 |
| GeneOntologyBiologicalProcess | blood circulation | 3.86e-04 | 648 | 57 | 8 | GO:0008015 | |
| GeneOntologyBiologicalProcess | muscle system process | 7.45e-04 | 547 | 57 | 7 | GO:0003012 | |
| GeneOntologyBiologicalProcess | secondary metabolic process | 8.46e-04 | 67 | 57 | 3 | GO:0019748 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | 8.46e-04 | 559 | 57 | 7 | GO:0042391 | |
| GeneOntologyBiologicalProcess | circulatory system process | 8.68e-04 | 733 | 57 | 8 | GO:0003013 | |
| GeneOntologyBiologicalProcess | regulation of sulfur metabolic process | 9.94e-04 | 17 | 57 | 2 | GO:0042762 | |
| GeneOntologyBiologicalProcess | glycosphingolipid metabolic process | 1.09e-03 | 73 | 57 | 3 | GO:0006687 | |
| GeneOntologyBiologicalProcess | ganglioside biosynthetic process | 1.12e-03 | 18 | 57 | 2 | GO:0001574 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A TMEM37 CATSPER3 PKD1L3 | 1.15e-03 | 1157 | 57 | 10 | GO:0006812 |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus | 1.17e-03 | 75 | 57 | 3 | GO:0050982 | |
| GeneOntologyBiologicalProcess | response to toxic substance | 1.20e-03 | 289 | 57 | 5 | GO:0009636 | |
| GeneOntologyBiologicalProcess | amide biosynthetic process | 1.31e-03 | 172 | 57 | 4 | GO:0043604 | |
| GeneOntologyBiologicalProcess | glutathione biosynthetic process | 1.38e-03 | 20 | 57 | 2 | GO:0006750 | |
| GeneOntologyBiologicalProcess | PERK-mediated unfolded protein response | 1.52e-03 | 21 | 57 | 2 | GO:0036499 | |
| GeneOntologyBiologicalProcess | nonribosomal peptide biosynthetic process | 1.67e-03 | 22 | 57 | 2 | GO:0019184 | |
| GeneOntologyBiologicalProcess | regulation of amide metabolic process | 1.86e-03 | 88 | 57 | 3 | GO:0034248 | |
| GeneOntologyBiologicalProcess | inflammatory response | PIK3AP1 ZDHHC12 NLRP7 NFE2L2 FPR2 SCN9A SERPINB1 SETD4 DAGLA | 2.10e-03 | 1043 | 57 | 9 | GO:0006954 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 1.46e-14 | 17 | 57 | 7 | GO:0001518 | |
| GeneOntologyCellularComponent | sodium channel complex | 1.14e-12 | 29 | 57 | 7 | GO:0034706 | |
| GeneOntologyCellularComponent | cation channel complex | 1.38e-08 | 235 | 57 | 9 | GO:0034703 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A TMEM37 CATSPER3 PKD1L3 | 6.73e-08 | 378 | 57 | 10 | GO:0034702 |
| GeneOntologyCellularComponent | transmembrane transporter complex | SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A TMEM37 CATSPER3 PKD1L3 | 1.33e-06 | 523 | 57 | 10 | GO:1902495 |
| GeneOntologyCellularComponent | transporter complex | SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A TMEM37 CATSPER3 PKD1L3 | 2.08e-06 | 550 | 57 | 10 | GO:1990351 |
| GeneOntologyCellularComponent | node of Ranvier | 2.12e-05 | 20 | 57 | 3 | GO:0033268 | |
| GeneOntologyCellularComponent | axon initial segment | 6.68e-05 | 29 | 57 | 3 | GO:0043194 | |
| GeneOntologyCellularComponent | main axon | 1.02e-04 | 89 | 57 | 4 | GO:0044304 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 2.53e-04 | 785 | 57 | 9 | GO:0098797 | |
| GeneOntologyCellularComponent | membrane protein complex | SPAG4 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A TMEM37 ITGA10 CATSPER3 PKD1L3 | 6.04e-04 | 1498 | 57 | 12 | GO:0098796 |
| GeneOntologyCellularComponent | intercalated disc | 8.50e-04 | 68 | 57 | 3 | GO:0014704 | |
| GeneOntologyCellularComponent | T-tubule | 1.31e-03 | 79 | 57 | 3 | GO:0030315 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 2.16e-03 | 94 | 57 | 3 | GO:0044291 | |
| GeneOntologyCellularComponent | axon | 2.74e-03 | 891 | 57 | 8 | GO:0030424 | |
| HumanPheno | Complex febrile seizure | 1.94e-07 | 16 | 18 | 4 | HP:0011172 | |
| HumanPheno | Focal hemiclonic seizure | 1.32e-06 | 25 | 18 | 4 | HP:0006813 | |
| HumanPheno | Simple febrile seizure | 1.82e-06 | 27 | 18 | 4 | HP:0011171 | |
| HumanPheno | Status epilepticus without prominent motor symptoms | 1.82e-06 | 27 | 18 | 4 | HP:0031475 | |
| HumanPheno | Photosensitive myoclonic seizure | 2.05e-06 | 8 | 18 | 3 | HP:0001327 | |
| HumanPheno | Cyanotic episode | 2.05e-06 | 8 | 18 | 3 | HP:0200048 | |
| HumanPheno | Status epilepticus | 3.59e-06 | 207 | 18 | 7 | HP:0002133 | |
| HumanPheno | Cogwheel rigidity | 3.69e-06 | 32 | 18 | 4 | HP:0002396 | |
| HumanPheno | Generalized clonic seizure | 4.74e-06 | 34 | 18 | 4 | HP:0011169 | |
| HumanPheno | Limited neck range of motion | 6.01e-06 | 11 | 18 | 3 | HP:0000466 | |
| HumanPheno | Clonic seizure | 6.54e-06 | 81 | 18 | 5 | HP:0020221 | |
| HumanPheno | Impulsivity | 7.86e-06 | 149 | 18 | 6 | HP:0100710 | |
| HumanPheno | Epilepsia partialis continua | 7.99e-06 | 12 | 18 | 3 | HP:0012847 | |
| HumanPheno | Focal automatism seizure | 7.99e-06 | 12 | 18 | 3 | HP:0032898 | |
| HumanPheno | Generalized cerebral atrophy/hypoplasia | 1.04e-05 | 13 | 18 | 3 | HP:0007058 | |
| HumanPheno | Focal clonic seizure | 1.12e-05 | 42 | 18 | 4 | HP:0002266 | |
| HumanPheno | Photosensitive tonic-clonic seizure | 1.64e-05 | 15 | 18 | 3 | HP:0007207 | |
| HumanPheno | Facial tics | 1.64e-05 | 15 | 18 | 3 | HP:0011468 | |
| HumanPheno | Abnormal hippocampus morphology | 1.93e-05 | 48 | 18 | 4 | HP:0025100 | |
| HumanPheno | Dysgenesis of the hippocampus | 2.02e-05 | 16 | 18 | 3 | HP:0025101 | |
| HumanPheno | Abnormal morphology of the limbic system | 2.09e-05 | 49 | 18 | 4 | HP:0007343 | |
| HumanPheno | Atypical absence status epilepticus | 2.44e-05 | 17 | 18 | 3 | HP:0011151 | |
| HumanPheno | Focal motor status epilepticus | 2.44e-05 | 17 | 18 | 3 | HP:0032663 | |
| HumanPheno | Visually-induced seizure | 2.93e-05 | 18 | 18 | 3 | HP:0020216 | |
| HumanPheno | Generalized non-convulsive status epilepticus without coma | 2.93e-05 | 18 | 18 | 3 | HP:0032860 | |
| HumanPheno | Pes valgus | 3.58e-05 | 56 | 18 | 4 | HP:0008081 | |
| HumanPheno | Cyanosis | 3.96e-05 | 117 | 18 | 5 | HP:0000961 | |
| HumanPheno | Non-convulsive status epilepticus without coma | 4.07e-05 | 20 | 18 | 3 | HP:0032671 | |
| HumanPheno | Talipes valgus | 4.74e-05 | 21 | 18 | 3 | HP:0004684 | |
| HumanPheno | Reflex seizure | 5.47e-05 | 22 | 18 | 3 | HP:0020207 | |
| HumanPheno | Focal impaired awareness seizure | 5.66e-05 | 126 | 18 | 5 | HP:0002384 | |
| HumanPheno | Generalized tonic seizure | 6.08e-05 | 64 | 18 | 4 | HP:0010818 | |
| HumanPheno | Rigidity | 6.22e-05 | 214 | 18 | 6 | HP:0002063 | |
| HumanPheno | Tibial torsion | 6.28e-05 | 23 | 18 | 3 | HP:0100694 | |
| HumanPheno | Multifocal epileptiform discharges | 6.86e-05 | 66 | 18 | 4 | HP:0010841 | |
| HumanPheno | Limited knee extension | 1.03e-04 | 27 | 18 | 3 | HP:0003066 | |
| HumanPheno | Infection-related seizure | 1.11e-04 | 145 | 18 | 5 | HP:0032892 | |
| HumanPheno | Seizure precipitated by febrile infection | 1.11e-04 | 145 | 18 | 5 | HP:0032894 | |
| HumanPheno | Febrile seizure (within the age range of 3 months to 6 years) | 1.11e-04 | 145 | 18 | 5 | HP:0002373 | |
| HumanPheno | Focal aware seizure | 1.15e-04 | 28 | 18 | 3 | HP:0002349 | |
| HumanPheno | Focal head nodding automatism seizure | 1.17e-04 | 5 | 18 | 2 | HP:0032906 | |
| HumanPheno | Neonatal electro-clinical non-motor seizure | 1.17e-04 | 5 | 18 | 2 | HP:0032812 | |
| HumanPheno | Neonatal seizure with electrographic correlate | 1.17e-04 | 5 | 18 | 2 | HP:0032808 | |
| HumanPheno | Neonatal electro-clinical seizure | 1.17e-04 | 5 | 18 | 2 | HP:0032809 | |
| HumanPheno | Neonatal electro-clinical seizure with behavior arrest | 1.17e-04 | 5 | 18 | 2 | HP:0032823 | |
| HumanPheno | Status epilepticus with prominent motor symptoms | 1.28e-04 | 29 | 18 | 3 | HP:0032658 | |
| HumanPheno | Progressive gait ataxia | 1.42e-04 | 30 | 18 | 3 | HP:0007240 | |
| HumanPheno | Progressive ataxia | 1.42e-04 | 30 | 18 | 3 | HP:0001329 | |
| HumanPheno | Myoclonus | 1.62e-04 | 371 | 18 | 7 | HP:0001336 | |
| HumanPheno | Compulsive behaviors | 1.66e-04 | 158 | 18 | 5 | HP:0000722 | |
| HumanPheno | Normal interictal EEG | 1.75e-04 | 6 | 18 | 2 | HP:0002372 | |
| HumanPheno | Obsessive-compulsive trait | 1.89e-04 | 33 | 18 | 3 | HP:0008770 | |
| HumanPheno | Calcaneovalgus deformity | 2.07e-04 | 34 | 18 | 3 | HP:0001848 | |
| HumanPheno | EEG with spike-wave complexes | 2.12e-04 | 88 | 18 | 4 | HP:0010850 | |
| HumanPheno | Deformed tarsal bones | 2.26e-04 | 35 | 18 | 3 | HP:0008119 | |
| HumanPheno | Limitation of knee mobility | 2.26e-04 | 35 | 18 | 3 | HP:0010501 | |
| HumanPheno | Eyelid myoclonia seizure | 2.45e-04 | 7 | 18 | 2 | HP:0032678 | |
| HumanPheno | Limitation of neck motion | 2.46e-04 | 36 | 18 | 3 | HP:0005986 | |
| HumanPheno | Disturbance of facial expression | 2.46e-04 | 36 | 18 | 3 | HP:0005324 | |
| HumanPheno | Abnormal neck physiology | 2.46e-04 | 36 | 18 | 3 | HP:0025669 | |
| HumanPheno | Focal non-motor seizure | 3.37e-04 | 40 | 18 | 3 | HP:0032679 | |
| HumanPheno | Impairment in personality functioning | PTCHD1 SCN1A SCN2A SCN3A SCN8A SCN9A SLC19A3 CLN6 TAC3 ABCA7 GNRHR | 4.47e-04 | 1141 | 18 | 11 | HP:0031466 |
| HumanPheno | Atypical absence seizure | 5.12e-04 | 46 | 18 | 3 | HP:0007270 | |
| HumanPheno | Apneic episodes in infancy | 5.22e-04 | 10 | 18 | 2 | HP:0005949 | |
| HumanPheno | Sudden unexpected death in epilepsy | 5.22e-04 | 10 | 18 | 2 | HP:0033258 | |
| HumanPheno | Neonatal seizure | 6.37e-04 | 11 | 18 | 2 | HP:0032807 | |
| HumanPheno | EEG with focal epileptiform discharges | 6.51e-04 | 118 | 18 | 4 | HP:0011185 | |
| HumanPheno | Epileptic encephalopathy | 6.72e-04 | 119 | 18 | 4 | HP:0200134 | |
| HumanPheno | Bilateral tonic-clonic seizure with focal onset | 7.35e-04 | 52 | 18 | 3 | HP:0007334 | |
| HumanPheno | Bilateral tonic-clonic seizure with generalized onset | 7.35e-04 | 52 | 18 | 3 | HP:0025190 | |
| HumanPheno | Focal-onset seizure | 8.66e-04 | 346 | 18 | 6 | HP:0007359 | |
| HumanPheno | Cortical dysplasia | 9.14e-04 | 56 | 18 | 3 | HP:0002539 | |
| HumanPheno | Abnormality of the calcaneus | 9.62e-04 | 57 | 18 | 3 | HP:0008364 | |
| HumanPheno | Focal motor seizure | 9.66e-04 | 131 | 18 | 4 | HP:0011153 | |
| HumanPheno | Involuntary movements | PTCHD1 NFE2L2 SCN1A SCN2A SCN3A SCN4A SCN8A SCN9A SLC19A3 CLN6 ABCA7 | 1.02e-03 | 1248 | 18 | 11 | HP:0004305 |
| HumanPheno | Abnormal volitional state | PTCHD1 SCN1A SCN2A SCN3A SCN8A SCN9A SLC19A3 CLN6 TAC3 ABCA7 GNRHR | 1.13e-03 | 1263 | 18 | 11 | HP:0025780 |
| HumanPheno | Abnormal motivation | PTCHD1 SCN1A SCN2A SCN3A SCN8A SCN9A SLC19A3 CLN6 TAC3 ABCA7 GNRHR | 1.13e-03 | 1263 | 18 | 11 | HP:5200275 |
| HumanPheno | Parkinsonism | 1.17e-03 | 138 | 18 | 4 | HP:0001300 | |
| HumanPheno | Aortopulmonary collateral arteries | 1.21e-03 | 15 | 18 | 2 | HP:0031834 | |
| HumanPheno | Tonic seizure | 1.24e-03 | 140 | 18 | 4 | HP:0032792 | |
| HumanPheno | Recurrent maladaptive behavior | PTCHD1 SCN1A SCN2A SCN3A SCN4A SCN8A SCN9A SLC19A3 TAC3 ABCA7 GNRHR | 1.40e-03 | 1293 | 18 | 11 | HP:5200241 |
| HumanPheno | Dialeptic seizure | 1.41e-03 | 251 | 18 | 5 | HP:0011146 | |
| HumanPheno | Generalized myoclonic seizure | 1.52e-03 | 148 | 18 | 4 | HP:0002123 | |
| HumanPheno | Focal emotional seizure with laughing | 1.55e-03 | 17 | 18 | 2 | HP:0010821 | |
| HumanPheno | Psychomotor regression | 1.63e-03 | 390 | 18 | 6 | HP:0002489 | |
| HumanPheno | Mental deterioration | 1.63e-03 | 390 | 18 | 6 | HP:0001268 | |
| HumanPheno | Poor fine motor coordination | 1.68e-03 | 69 | 18 | 3 | HP:0007010 | |
| HumanPheno | Bilateral tonic-clonic seizure | 1.72e-03 | 394 | 18 | 6 | HP:0002069 | |
| HumanPheno | Gait ataxia | 1.74e-03 | 263 | 18 | 5 | HP:0002066 | |
| HumanPheno | Increased female libido | 1.75e-03 | 18 | 18 | 2 | HP:0030019 | |
| HumanPheno | Focal emotional seizure | 1.75e-03 | 18 | 18 | 2 | HP:0025613 | |
| HumanPheno | Increased libido | 1.75e-03 | 18 | 18 | 2 | HP:0046503 | |
| HumanPheno | EEG with generalized epileptiform discharges | 1.95e-03 | 270 | 18 | 5 | HP:0011198 | |
| HumanPheno | Psychomotor deterioration | 2.16e-03 | 20 | 18 | 2 | HP:0002361 | |
| HumanPheno | Confusion | 2.30e-03 | 77 | 18 | 3 | HP:0001289 | |
| HumanPheno | Focal sensory seizure | 2.61e-03 | 22 | 18 | 2 | HP:0011157 | |
| HumanPheno | Eunuchoid habitus | 2.61e-03 | 22 | 18 | 2 | HP:0003782 | |
| HumanPheno | Motor seizure | 2.62e-03 | 586 | 18 | 7 | HP:0020219 | |
| HumanPheno | Cerebral palsy | 2.82e-03 | 175 | 18 | 4 | HP:0100021 | |
| HumanPheno | Focal tonic seizure | 2.86e-03 | 23 | 18 | 2 | HP:0011167 | |
| MousePheno | abnormal action potential | 4.12e-05 | 133 | 41 | 5 | MP:0005402 | |
| MousePheno | abnormal nervous system electrophysiology | 4.24e-05 | 329 | 41 | 7 | MP:0002272 | |
| MousePheno | abnormal single cell response | 1.44e-04 | 35 | 41 | 3 | MP:0003463 | |
| MousePheno | hindlimb paresis | 1.70e-04 | 37 | 41 | 3 | MP:0031204 | |
| MousePheno | ventricular fibrillation | 1.75e-04 | 7 | 41 | 2 | MP:0006110 | |
| MousePheno | astrocytosis | 2.28e-04 | 103 | 41 | 4 | MP:0003354 | |
| MousePheno | increased astrocyte number | 2.64e-04 | 107 | 41 | 4 | MP:0012065 | |
| Domain | Na_channel_asu | 2.01e-16 | 10 | 57 | 7 | IPR001696 | |
| Domain | Na_trans_assoc | 2.01e-16 | 10 | 57 | 7 | IPR010526 | |
| Domain | Na_trans_assoc | 2.01e-16 | 10 | 57 | 7 | PF06512 | |
| Domain | Na_trans_cytopl | 6.16e-16 | 6 | 57 | 6 | PF11933 | |
| Domain | Na_trans_cytopl | 6.16e-16 | 6 | 57 | 6 | IPR024583 | |
| Domain | Channel_four-helix_dom | 3.96e-10 | 57 | 57 | 7 | IPR027359 | |
| Domain | - | 3.96e-10 | 57 | 57 | 7 | 1.20.120.350 | |
| Domain | Ion_trans_dom | 1.94e-09 | 114 | 57 | 8 | IPR005821 | |
| Domain | Ion_trans | 1.94e-09 | 114 | 57 | 8 | PF00520 | |
| Domain | IQ | 4.92e-09 | 81 | 57 | 7 | SM00015 | |
| Domain | GPCR_Rhodpsn_7TM | OR2C1 OR4K17 HTR6 OR1I1 OR7C1 FPR2 OR2G3 OR1A1 GPR152 OR1E1 OR1E2 OR7G2 GNRHR S1PR4 | 9.42e-09 | 670 | 57 | 14 | IPR017452 |
| Domain | IQ_motif_EF-hand-BS | 1.03e-08 | 90 | 57 | 7 | IPR000048 | |
| Domain | 7tm_1 | OR2C1 OR4K17 HTR6 OR1I1 OR7C1 FPR2 OR2G3 OR1A1 GPR152 OR1E1 OR1E2 OR7G2 GNRHR S1PR4 | 1.07e-08 | 677 | 57 | 14 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR2C1 OR4K17 HTR6 OR1I1 OR7C1 FPR2 OR2G3 OR1A1 GPR152 OR1E1 OR1E2 OR7G2 GNRHR S1PR4 | 1.25e-08 | 685 | 57 | 14 | PS00237 |
| Domain | IQ | 1.30e-08 | 93 | 57 | 7 | PS50096 | |
| Domain | G_PROTEIN_RECEP_F1_2 | OR2C1 OR4K17 HTR6 OR1I1 OR7C1 FPR2 OR2G3 OR1A1 GPR152 OR1E1 OR1E2 OR7G2 GNRHR S1PR4 | 1.39e-08 | 691 | 57 | 14 | PS50262 |
| Domain | GPCR_Rhodpsn | OR2C1 OR4K17 HTR6 OR1I1 OR7C1 FPR2 OR2G3 OR1A1 GPR152 OR1E1 OR1E2 OR7G2 GNRHR S1PR4 | 1.42e-08 | 692 | 57 | 14 | IPR000276 |
| Domain | IQ | 2.47e-06 | 71 | 57 | 5 | PF00612 | |
| Domain | Olfact_rcpt | 2.72e-06 | 393 | 57 | 9 | IPR000725 | |
| Domain | Serpin_CS | 1.26e-04 | 32 | 57 | 3 | IPR023795 | |
| Domain | Serpin_dom | 1.79e-04 | 36 | 57 | 3 | IPR023796 | |
| Domain | Galactosyl_T | 1.90e-04 | 7 | 57 | 2 | IPR003859 | |
| Domain | Galactosyl_T_C | 1.90e-04 | 7 | 57 | 2 | IPR027791 | |
| Domain | Galactosyl_T_N | 1.90e-04 | 7 | 57 | 2 | IPR027995 | |
| Domain | Glyco_transf_7C | 1.90e-04 | 7 | 57 | 2 | PF02709 | |
| Domain | Glyco_transf_7N | 1.90e-04 | 7 | 57 | 2 | PF13733 | |
| Domain | SERPIN | 1.95e-04 | 37 | 57 | 3 | SM00093 | |
| Domain | SERPIN | 1.95e-04 | 37 | 57 | 3 | PS00284 | |
| Domain | Serpin | 2.11e-04 | 38 | 57 | 3 | PF00079 | |
| Domain | Serpin_fam | 2.28e-04 | 39 | 57 | 3 | IPR000215 | |
| Domain | ABC_A | 5.92e-04 | 12 | 57 | 2 | IPR026082 | |
| Domain | ABC_TRANSPORTER_2 | 9.43e-03 | 48 | 57 | 2 | PS50893 | |
| Domain | ABC_tran | 9.43e-03 | 48 | 57 | 2 | PF00005 | |
| Domain | ABC_TRANSPORTER_1 | 9.82e-03 | 49 | 57 | 2 | PS00211 | |
| Domain | ABC_transporter-like | 1.02e-02 | 50 | 57 | 2 | IPR003439 | |
| Domain | EF-hand-dom_pair | 1.14e-02 | 287 | 57 | 4 | IPR011992 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 5.14e-12 | 31 | 45 | 7 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 6.57e-12 | 32 | 45 | 7 | M27455 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 3.86e-09 | 121 | 45 | 8 | M872 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 1.63e-07 | 130 | 45 | 7 | M27454 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | PIK3AP1 HTR6 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A DAGLA | 1.79e-07 | 367 | 45 | 10 | M48346 |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR2C1 OR4K17 OR1I1 OR7C1 SCN2A SCN3A OR2G3 OR1A1 SCN9A OR1E1 OR1E2 OR7G2 | 4.69e-07 | 636 | 45 | 12 | M41834 |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 1.44e-06 | 260 | 45 | 8 | M39397 | |
| Pathway | WP_DRAVET_SYNDROME | 1.75e-06 | 28 | 45 | 4 | M45519 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 2.73e-06 | 70 | 45 | 5 | MM14984 | |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | 3.11e-06 | 389 | 45 | 9 | M14091 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 3.30e-06 | 203 | 45 | 7 | M5485 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 5.48e-06 | 417 | 45 | 9 | M4072 | |
| Pathway | WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A | 2.07e-04 | 7 | 45 | 2 | M42540 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 3.33e-04 | 190 | 45 | 5 | MM15687 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 4.14e-04 | 575 | 45 | 8 | M29853 | |
| Pathway | REACTOME_SENSORY_PERCEPTION_OF_TASTE | 4.47e-04 | 47 | 45 | 3 | M42524 | |
| Pathway | WP_RETT_SYNDROME | 4.76e-04 | 48 | 45 | 3 | M39759 | |
| Pathway | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION | 1.02e-03 | 15 | 45 | 2 | M966 | |
| Pathway | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION | 1.02e-03 | 15 | 45 | 2 | MM15700 | |
| Pathway | WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS | 1.02e-03 | 15 | 45 | 2 | M39498 | |
| Pathway | WP_GPCRS_ODORANT | 1.55e-03 | 157 | 45 | 4 | MM15872 | |
| Pathway | REACTOME_GLYCOSPHINGOLIPID_BIOSYNTHESIS | 1.65e-03 | 19 | 45 | 2 | MM17075 | |
| Pathway | REACTOME_GLYCOSPHINGOLIPID_BIOSYNTHESIS | 1.65e-03 | 19 | 45 | 2 | M48041 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ANTI_OXIDANT_DETOXIFICATION_ENZYMES | 1.65e-03 | 19 | 45 | 2 | M46442 | |
| Pathway | WP_GLYCOSPHINGOLIPID_METABOLISM | 2.01e-03 | 21 | 45 | 2 | M46462 | |
| Pathway | WP_NRF2ARE_REGULATION | 2.42e-03 | 23 | 45 | 2 | M39761 | |
| Pathway | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI | 3.08e-03 | 26 | 45 | 2 | M979 | |
| Pathway | WP_GPCRS_OTHER | 3.53e-03 | 96 | 45 | 3 | MM15939 | |
| Pathway | REACTOME_KERATAN_SULFATE_BIOSYNTHESIS | 3.57e-03 | 28 | 45 | 2 | M670 | |
| Pathway | REACTOME_KERATAN_SULFATE_BIOSYNTHESIS | 3.57e-03 | 28 | 45 | 2 | MM14798 | |
| Pathway | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI | 3.83e-03 | 29 | 45 | 2 | MM15699 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 3.87e-03 | 330 | 45 | 5 | M18334 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 4.02e-03 | 333 | 45 | 5 | MM14963 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 4.42e-03 | 210 | 45 | 4 | MM15043 | |
| Pathway | WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY | 4.65e-03 | 32 | 45 | 2 | M42560 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 4.97e-03 | 217 | 45 | 4 | M18437 | |
| Pathway | REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM | 5.86e-03 | 36 | 45 | 2 | M690 | |
| Pathway | REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM | 5.86e-03 | 36 | 45 | 2 | MM14632 | |
| Pubmed | 7.78e-19 | 9 | 57 | 7 | 16382098 | ||
| Pubmed | 1.24e-15 | 9 | 57 | 6 | 15746173 | ||
| Pubmed | 9.88e-15 | 5 | 57 | 5 | 17724025 | ||
| Pubmed | 2.51e-14 | 13 | 57 | 6 | 15123669 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 5.92e-14 | 6 | 57 | 5 | 23652591 | |
| Pubmed | 6.48e-12 | 4 | 57 | 4 | 17537961 | ||
| Pubmed | 6.48e-12 | 4 | 57 | 4 | 35031483 | ||
| Pubmed | 6.48e-12 | 4 | 57 | 4 | 29578003 | ||
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 7.75e-12 | 12 | 57 | 5 | 30175250 | |
| Pubmed | 3.24e-11 | 5 | 57 | 4 | 8812438 | ||
| Pubmed | Early development of electrical excitability in the mouse enteric nervous system. | 3.24e-11 | 5 | 57 | 4 | 22875929 | |
| Pubmed | Odorant and vomeronasal receptor genes in two mouse genome assemblies. | 2.51e-09 | 74 | 57 | 6 | 15081110 | |
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 19284629 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 12610651 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 33895391 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 23859570 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 18784617 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 17544618 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 32845893 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 20038812 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 28518218 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 17928448 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 14973256 | ||
| Pubmed | 1.67e-08 | 4 | 57 | 3 | 21156207 | ||
| Pubmed | 1.67e-08 | 4 | 57 | 3 | 35801810 | ||
| Pubmed | Use of recombinant inbred strains for studying genetic determinants of responses to alcohol. | 1.67e-08 | 4 | 57 | 3 | 8974318 | |
| Pubmed | 4.16e-08 | 5 | 57 | 3 | 1679748 | ||
| Pubmed | 4.16e-08 | 5 | 57 | 3 | 24337656 | ||
| Pubmed | 5.61e-08 | 23 | 57 | 4 | 10706615 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 1.12e-07 | 139 | 57 | 6 | 16985003 | |
| Pubmed | Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. | 1.45e-07 | 7 | 57 | 3 | 25818041 | |
| Pubmed | 1.45e-07 | 7 | 57 | 3 | 15272007 | ||
| Pubmed | Mouse-human orthology relationships in an olfactory receptor gene cluster. | 2.32e-07 | 8 | 57 | 3 | 11170746 | |
| Pubmed | 2.32e-07 | 8 | 57 | 3 | 9412493 | ||
| Pubmed | Sodium channel Scn1b null mice exhibit prolonged QT and RR intervals. | 3.48e-07 | 9 | 57 | 3 | 17884088 | |
| Pubmed | 9.09e-07 | 12 | 57 | 3 | 8169823 | ||
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | 1.39e-06 | 340 | 57 | 7 | 11875048 | |
| Pubmed | 1.39e-06 | 340 | 57 | 7 | 11802173 | ||
| Pubmed | 1.48e-06 | 343 | 57 | 7 | 32295537 | ||
| Pubmed | 1.50e-06 | 14 | 57 | 3 | 7528109 | ||
| Pubmed | 1.57e-06 | 346 | 57 | 7 | 14611657 | ||
| Pubmed | DEFOG: a practical scheme for deciphering families of genes. | 1.62e-06 | 219 | 57 | 6 | 12213199 | |
| Pubmed | Confirmation of quantitative trait loci for alcohol preference in mice. | 1.87e-06 | 15 | 57 | 3 | 9726281 | |
| Pubmed | Sequence, structure, and evolution of a complete human olfactory receptor gene cluster. | 2.30e-06 | 16 | 57 | 3 | 10673334 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 29649454 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 20346423 | ||
| Pubmed | Reduction of Kcnt1 is therapeutic in mouse models of SCN1A and SCN8A epilepsy. | 2.64e-06 | 2 | 57 | 2 | 37901435 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 18079277 | ||
| Pubmed | An Scn1a epilepsy mutation in Scn8a alters seizure susceptibility and behavior. | 2.64e-06 | 2 | 57 | 2 | 26410685 | |
| Pubmed | Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice. | 2.64e-06 | 2 | 57 | 2 | 10827969 | |
| Pubmed | β4GalT6 is involved in the synthesis of lactosylceramide with less intensity than β4GalT5. | 2.64e-06 | 2 | 57 | 2 | 23882130 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 19694741 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 35348308 | ||
| Pubmed | Genomic structures of SCN2A and SCN3A - candidate genes for deafness at the DFNA16 locus. | 2.64e-06 | 2 | 57 | 2 | 11245985 | |
| Pubmed | Establishment of HeLa cell mutants deficient in sphingolipid-related genes using TALENs. | 2.64e-06 | 2 | 57 | 2 | 24498430 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 26861708 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 15760941 | ||
| Pubmed | Differential expression of two sodium channel subtypes in human brain. | 2.64e-06 | 2 | 57 | 2 | 1317301 | |
| Pubmed | Duplication of the sodium channel gene cluster on 2q24 in children with early onset epilepsy. | 2.64e-06 | 2 | 57 | 2 | 23016767 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 28429737 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 27153334 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 33096315 | ||
| Pubmed | Electrophysiological Differences between the Same Pore Region Mutation in SCN1A and SCN3A. | 2.64e-06 | 2 | 57 | 2 | 24990319 | |
| Pubmed | Ca2+-dependent regulation of sodium channels NaV1.4 and NaV1.5 is controlled by the post-IQ motif. | 2.64e-06 | 2 | 57 | 2 | 30944319 | |
| Pubmed | Na+ current properties in islet α- and β-cells reflect cell-specific Scn3a and Scn9a expression. | 2.64e-06 | 2 | 57 | 2 | 25172946 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 31439038 | ||
| Pubmed | NRF2 Antagonizes HIV-1 Tat and Methamphetamine-Induced BV2 Cell Ferroptosis by Regulating SLC7A11. | 2.64e-06 | 2 | 57 | 2 | 37060393 | |
| Pubmed | Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. | 2.64e-06 | 2 | 57 | 2 | 16054936 | |
| Pubmed | Sodium channel expression within chronic multiple sclerosis plaques. | 2.64e-06 | 2 | 57 | 2 | 17805013 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 33712547 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 26311622 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 33411788 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 34446045 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 31943325 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 11834499 | ||
| Pubmed | Severe epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2A. | 2.64e-06 | 2 | 57 | 2 | 15249644 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 27690330 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 21993616 | ||
| Pubmed | Sodium channel slow inactivation interferes with open channel block. | 2.64e-06 | 2 | 57 | 2 | 27174182 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 21377452 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 18601978 | ||
| Pubmed | Correlations in timing of sodium channel expression, epilepsy, and sudden death in Dravet syndrome. | 2.64e-06 | 2 | 57 | 2 | 23965409 | |
| Pubmed | FGF14 N-terminal splice variants differentially modulate Nav1.2 and Nav1.6-encoded sodium channels. | 2.64e-06 | 2 | 57 | 2 | 19465131 | |
| Pubmed | Isoform-specific effects of the beta2 subunit on voltage-gated sodium channel gating. | 2.64e-06 | 2 | 57 | 2 | 16847056 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 30114188 | ||
| Pubmed | Persistent Nav1.1 and Nav1.6 currents drive spinal locomotor functions through nonlinear dynamics. | 2.64e-06 | 2 | 57 | 2 | 37665666 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 17881658 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 30693367 | ||
| Pubmed | Block of a subset of sodium channels exacerbates experimental autoimmune encephalomyelitis. | 2.64e-06 | 2 | 57 | 2 | 23735284 | |
| Pubmed | 2.75e-06 | 541 | 57 | 8 | 14983052 | ||
| Pubmed | Olfactory receptors and signalling elements in the Grueneberg ganglion. | 2.79e-06 | 17 | 57 | 3 | 16805845 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 28784306 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 32185219 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 32005694 | ||
| Pubmed | Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation. | 7.91e-06 | 3 | 57 | 2 | 25216636 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 15316014 | ||
| Pubmed | NRF2 Is a Major Target of ARF in p53-Independent Tumor Suppression. | 7.91e-06 | 3 | 57 | 2 | 28985506 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 19699781 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 16033895 | ||
| Pubmed | Role of sodium channel subtype in action potential generation by neocortical pyramidal neurons. | 7.91e-06 | 3 | 57 | 2 | 29991598 | |
| Interaction | SCN11A interactions | 6.63e-08 | 15 | 55 | 4 | int:SCN11A | |
| Interaction | SCN4B interactions | 1.07e-06 | 8 | 55 | 3 | int:SCN4B | |
| Interaction | NALCN interactions | 6.85e-06 | 14 | 55 | 3 | int:NALCN | |
| Interaction | SCN5A interactions | 8.12e-06 | 47 | 55 | 4 | int:SCN5A | |
| Interaction | SCN8A interactions | 2.12e-05 | 20 | 55 | 3 | int:SCN8A | |
| Interaction | SCN9A interactions | 2.47e-05 | 21 | 55 | 3 | int:SCN9A | |
| Interaction | CACNA1D interactions | 3.74e-05 | 24 | 55 | 3 | int:CACNA1D | |
| Interaction | ERMP1 interactions | 5.00e-05 | 147 | 55 | 5 | int:ERMP1 | |
| Interaction | SCN1A interactions | 6.68e-05 | 29 | 55 | 3 | int:SCN1A | |
| Interaction | AVP interactions | 8.19e-05 | 31 | 55 | 3 | int:AVP | |
| Interaction | CACNA1B interactions | 1.40e-04 | 37 | 55 | 3 | int:CACNA1B | |
| Interaction | NEDD4L interactions | 2.30e-04 | 320 | 55 | 6 | int:NEDD4L | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 1.97e-05 | 127 | 57 | 4 | chr2q24 | |
| Cytoband | 2q24 | 8.27e-05 | 11 | 57 | 2 | 2q24 | |
| Cytoband | 2q24.3 | 1.80e-04 | 16 | 57 | 2 | 2q24.3 | |
| Cytoband | 17p13.3 | 1.85e-04 | 88 | 57 | 3 | 17p13.3 | |
| Cytoband | 2q37 | 6.88e-04 | 31 | 57 | 2 | 2q37 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 3.10e-03 | 797 | 57 | 5 | chr19p13 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 2.11e-17 | 9 | 48 | 7 | 1203 | |
| GeneFamily | Olfactory receptors, family 1 | 3.72e-06 | 40 | 48 | 4 | 147 | |
| GeneFamily | Serpin peptidase inhibitors | 1.28e-04 | 37 | 48 | 3 | 739 | |
| GeneFamily | ATP binding cassette subfamily A | 6.15e-04 | 14 | 48 | 2 | 805 | |
| GeneFamily | Beta 4-glycosyltransferases | 9.15e-04 | 17 | 48 | 2 | 425 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN | 4.62e-05 | 32 | 57 | 3 | M17990 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN | 5.08e-05 | 33 | 57 | 3 | MM783 | |
| Coexpression | GSE2706_R848_VS_R848_AND_LPS_8H_STIM_DC_DN | 6.95e-05 | 197 | 57 | 5 | M4720 | |
| Coexpression | GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_DN | 7.12e-05 | 198 | 57 | 5 | M3401 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_180MIN_DN | 7.46e-05 | 200 | 57 | 5 | M6624 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.80e-07 | 194 | 57 | 6 | e0228f593c3493175962a4817500d4337ddc4e88 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.07e-06 | 195 | 57 | 5 | e7230a849ea31e6eef9bc6f5468938499450582d | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_plasmacytoid|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.19e-06 | 196 | 57 | 5 | b10b386aacc672949560df2dbb0d4f76cf62e213 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chodl|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.87e-05 | 137 | 57 | 4 | 5cb84392e4483f50e09fb7395e2ec98f3eb6ecf3 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-B_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.03e-05 | 139 | 57 | 4 | aefcfda2b2db302ce4b3d2a09f767be0b1c3ac6c | |
| ToppCell | 356C-Epithelial_cells-Epithelial-B_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.03e-05 | 139 | 57 | 4 | b9c2dfab119ac0efdf931bb2910e82bccdb4e48d | |
| ToppCell | Immune_cells-Neutrophils|World / Lineage and Cell class | 4.19e-05 | 151 | 57 | 4 | 056301bedb4285e797250b55d79ee1790a17516d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.19e-05 | 151 | 57 | 4 | f41c6558a5874b6464c157027fdf202257c60e5b | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.65e-05 | 163 | 57 | 4 | abec4389cd88252449f110fe95416d67424b403a | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.65e-05 | 163 | 57 | 4 | 360cd65decda24853124f33a174f5224d7f3ce23 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like-AT1_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.65e-05 | 163 | 57 | 4 | b59d9b4f7c9f4e5e2c7783a49a96729dae3a81e5 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.50e-05 | 169 | 57 | 4 | 2456b3e7776e8a2214972be1b4d66a3ca5480ae0 | |
| ToppCell | BAL-Control-Myeloid-pDC-pDC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.27e-05 | 174 | 57 | 4 | ab654e87c7eab7f33adc61be7a86da5c4d88008d | |
| ToppCell | BAL-Control-Myeloid-pDC-pDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.27e-05 | 174 | 57 | 4 | 2453419842fd22d066631615403393bfe4449bb8 | |
| ToppCell | BAL-Control-Myeloid-pDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.27e-05 | 174 | 57 | 4 | d9bccff5258c4277bdd1edbd87e17c327ec125e8 | |
| ToppCell | BAL-Control-Myeloid-pDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.44e-05 | 175 | 57 | 4 | 6d5bdfbe53608e01c3845ecd908ca6d0fecc58f8 | |
| ToppCell | BAL-Control-Myeloid-pDC-pDC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.44e-05 | 175 | 57 | 4 | 6839ee3bb4457d13cb08ca8eb79ae33ddd256783 | |
| ToppCell | BAL-Control-Myeloid-pDC-pDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.44e-05 | 175 | 57 | 4 | 9d6135e183179968555670abec39dff9da2c3219 | |
| ToppCell | Control-Myeloid-pDC|Control / Disease group,lineage and cell class （2021.01.30） | 7.60e-05 | 176 | 57 | 4 | baa3563973ea1a351fe028f55828463d2a51bf1a | |
| ToppCell | facs-Heart-LA-24m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.77e-05 | 177 | 57 | 4 | a3f8c26d54e44688bbd678ac7ef55d8ad172617d | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal-Suprabasal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.29e-05 | 180 | 57 | 4 | 535a890bde0d978b461c2d4c571529b585c76b21 | |
| ToppCell | 11.5-Airway-Immune-Hematopoietic,_B_Cells|Airway / Age, Tissue, Lineage and Cell class | 8.47e-05 | 181 | 57 | 4 | 727344d7b2953568b7b3463398c7d56878cf2c2b | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.47e-05 | 181 | 57 | 4 | 7f99002a6411117cc2361334c7c9228e20c574b4 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.66e-05 | 182 | 57 | 4 | 52eac2f892ea7f26731e0b21c578fd2665a1657a | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 9.03e-05 | 184 | 57 | 4 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_B|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.61e-05 | 187 | 57 | 4 | 9d298f43ae81d72091b31aaa6df41046d4aa31c5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.81e-05 | 188 | 57 | 4 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 9.81e-05 | 188 | 57 | 4 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 9.81e-05 | 188 | 57 | 4 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-04 | 189 | 57 | 4 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-04 | 190 | 57 | 4 | bdbfaced785db79ff965f332759be258dbf743cf | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)|10x_3'_v3 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.06e-04 | 192 | 57 | 4 | 072281344d58e85c9a290750b488d0c101f75d54 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.11e-04 | 194 | 57 | 4 | 15224fb3e7ca5bd1fb8c41f8275842f737014095 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-basal_bladder_epithelial_cell_(Krt5+Krt14+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 194 | 57 | 4 | 37803f4abf1aa1ad771c9cd293933003d7101e70 | |
| ToppCell | PCW_13-14-Hematologic_ErythroMegGranulo-Hem_Granulocytic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.11e-04 | 194 | 57 | 4 | 6b48383151b678489bcd6133d389a5d8b3a50186 | |
| ToppCell | COVID_vent-Myeloid-Monocytic-Developing_Neutrophil|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.13e-04 | 195 | 57 | 4 | de23409b1b4146b8ae286850b829ec8dceed0117 | |
| ToppCell | COVID-19_Severe|World / Disease condition and Cell class | 1.13e-04 | 195 | 57 | 4 | 22f56ccb81967bff54a1f90e949a8dfc2ce0e4ab | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.13e-04 | 195 | 57 | 4 | 24d226f89dd337c22728688e4b40ca082a0e1fe1 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.15e-04 | 196 | 57 | 4 | b07db4a53ab9be9aad6fae5e45f9547db829d096 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-04 | 196 | 57 | 4 | f40d10ea7714067585493fdc89744714aa427de8 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.15e-04 | 196 | 57 | 4 | c366f980cc04abfe1c0c14746c11810c812a42c0 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-04 | 196 | 57 | 4 | b8350340d86e4524e9616a427e7f2e116a6fb3be | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-04 | 197 | 57 | 4 | 233b9fcb376e08d0080a05ca0198ecc6ec720f90 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-neutrophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.20e-04 | 198 | 57 | 4 | 82f6ac18c3a6487f03579b5c247844f1c115c2be | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.20e-04 | 198 | 57 | 4 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.20e-04 | 198 | 57 | 4 | f870e398e996c1f28c8462d87b18f71b20c71011 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.20e-04 | 198 | 57 | 4 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.20e-04 | 198 | 57 | 4 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Sepsis-URO|Sepsis / Disease, condition lineage and cell class | 1.22e-04 | 199 | 57 | 4 | 8e6dac82d1d0e759cd567f9c95b70cb4801d7caf | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.22e-04 | 199 | 57 | 4 | e03bdc7cb825e287f41b834ec6061d23c1c03b04 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.24e-04 | 200 | 57 | 4 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.24e-04 | 200 | 57 | 4 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.24e-04 | 200 | 57 | 4 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | severe-immature_Neutrophil|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.24e-04 | 200 | 57 | 4 | a9b87accdaa6956116ab82427e1330e8f007ef94 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.24e-04 | 200 | 57 | 4 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.24e-04 | 200 | 57 | 4 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.24e-04 | 200 | 57 | 4 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7-Slc17a8.Syt6-Cplx3_(Deep_layer_pyramidal_cells--Cortical_Subplate)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.37e-04 | 78 | 57 | 3 | 46e31ebb3afc08bf414a5793cd9b4320bf4375c5 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7-Slc17a8.Syt6-Cplx3_(Deep_layer_pyramidal_cells--Cortical_Subplate)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.37e-04 | 78 | 57 | 3 | 869fcbc0c308164101c0e4e0494c6a75c2f6f94e | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Serous_adenocarcinoma-2|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 3.30e-04 | 105 | 57 | 3 | 744be8b4255bef3a973db7e4306e52387852e502 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.62e-04 | 126 | 57 | 3 | 6cb89754010d64875e115da6c5805efac7a4a82d | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.62e-04 | 126 | 57 | 3 | 69b2525b92d1c7c35b21cc701f5fa52a9c1b94bb | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Inner_Medullary_Collecting_Duct_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.15e-04 | 130 | 57 | 3 | 00b5e0e5c54897cee1dc094789e8cf75d8f428c2 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Col8a1_Rxfp1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.29e-04 | 131 | 57 | 3 | 81efe8b0ca4377e557a42ddb12aecaf3f46b15bf | |
| ToppCell | COVID_non-vent-Myeloid-Monocytic-Developing_Neutrophil|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 6.29e-04 | 131 | 57 | 3 | 5b29f0dc449b9fff5e8bf6365080168f31b7e268 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesenchymal_stem_cell|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 7.17e-04 | 137 | 57 | 3 | ed81624b9167255ce88dcf6ad7f1636376ea0525 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesenchymal_stem_cell-Mesenchymal_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 7.17e-04 | 137 | 57 | 3 | 47859aa25f32367461c1ec75ed9060bee430c6b7 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.95e-04 | 142 | 57 | 3 | 819e983688d126d89a71abc03d72525cc759a347 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.95e-04 | 142 | 57 | 3 | 5b6b0c611c83b23ef7289854a515b78f6cf84500 | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.11e-04 | 143 | 57 | 3 | 8f82b3c3331f20c6ded36dbfb9a48dbd9f099f93 | |
| ToppCell | facs-Skin-Anagen-3m-Myeloid|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.11e-04 | 143 | 57 | 3 | 250f60f06f262f00acd14b09b3ef90dbb9759336 | |
| ToppCell | facs-Skin-Anagen-3m-Myeloid-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.11e-04 | 143 | 57 | 3 | 0c7c0d7ca040e87412295672cd1f065c0e941391 | |
| ToppCell | facs-Skin-Anagen-3m-Myeloid-macrophage|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.11e-04 | 143 | 57 | 3 | 27f4896276342758651fe7a80d7408ac5e1be9c0 | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.11e-04 | 143 | 57 | 3 | 52832321cc848739ff6483f467d57c50c8b7395c | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Immune-B_cells|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.45e-04 | 145 | 57 | 3 | 34cff6df39ff05995041f0c231c60a50ad1a0c1c | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.45e-04 | 145 | 57 | 3 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Granulocytic-Neutrophil|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.45e-04 | 145 | 57 | 3 | 88e463d5396a8fea2b7b1ecf3c9b144e16b35234 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.45e-04 | 145 | 57 | 3 | 911fee7f27694393e348d94470a1a4e890038902 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_Invariant-Inducer-like-ILC3|bone_marrow / Manually curated celltypes from each tissue | 9.14e-04 | 149 | 57 | 3 | d7f1069f70f3cad6d3700ee2041ed1d4cb7c49ab | |
| ToppCell | droplet-Kidney-nan-24m-Lymphocytic-CD45____macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.31e-04 | 150 | 57 | 3 | 34774b015adecc2be56a471fda8994e89a6ad93e | |
| ToppCell | COVID-19-Mast_cells-Monocyte-derived_macrophages|COVID-19 / group, cell type (main and fine annotations) | 9.31e-04 | 150 | 57 | 3 | 10697c2d22cb25376827cc7c570ff1adc94c1acd | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.49e-04 | 151 | 57 | 3 | 771224e0d6fccfa4225b3adccd7bc22a89a40793 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.49e-04 | 151 | 57 | 3 | 5893a51585a65f1902cf85124a5ed9f02b4eb82a | |
| ToppCell | Healthy_donor-B_cell|Healthy_donor / disease group, cell group and cell class (v2) | 9.68e-04 | 152 | 57 | 3 | 5768edfde8010324d8594815e73bbfba2c3045f3 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Immune-B_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 9.68e-04 | 152 | 57 | 3 | 66f9190de155251a63a7a669374f342a75d22ea0 | |
| ToppCell | PND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.68e-04 | 152 | 57 | 3 | b750302d442160a1007659c2386ac90282bf95d2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.86e-04 | 153 | 57 | 3 | c1335e7d7407412431ed4d8c7dfcb2c6086d8483 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.86e-04 | 153 | 57 | 3 | d6526d17826470534b766df144c74e73eb83fdad | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-Klrb1a/b/c(-)_NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.86e-04 | 153 | 57 | 3 | cb144b8c487286384b47fdff88ff98fcf0508899 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Lymphocytic-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-03 | 154 | 57 | 3 | 3fa6f77ad2c30ec24b9b904e2732ec5b419dff5b | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Lymphocytic|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-03 | 154 | 57 | 3 | ee03b386d28a524084eaf1c0091f7389daa34250 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.02e-03 | 155 | 57 | 3 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 1.04e-03 | 156 | 57 | 3 | 19472ef1642c2ad333aa3ce3675a25c6ab1d4556 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-intermediate_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-03 | 156 | 57 | 3 | 69e6e8810d1738a66c9821910f41498931cf30cc | |
| ToppCell | facs-Lung-nan-3m-Myeloid-Intermediate_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-03 | 156 | 57 | 3 | 3f0b9e35d4da85c90759b930052e5b9c3cde9b15 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-03 | 157 | 57 | 3 | 9021900d9b1a71210c9c414a9d165eaf399eb607 | |
| ToppCell | droplet-Liver-Npc-21m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-03 | 157 | 57 | 3 | 264b22d0ffc43049161843bb55d2eccbf5fca575 | |
| ToppCell | facs-Trachea-18m-Hematologic-myeloid-granulocyte-granulocyte_l8|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.06e-03 | 157 | 57 | 3 | 5098675f64342c41c5ca3551b24962d10c83e64d | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-03 | 157 | 57 | 3 | c8c627ca181856cd31dba4cf073c2be659a49dc1 | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Myeloid-macrophage|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-03 | 157 | 57 | 3 | 042129d1b514dc4ed8a5f45b52d9c73cf4807636 | |
| Drug | Zonisamide | 2.04e-12 | 17 | 56 | 6 | DB00909 | |
| Drug | lamotrigine | 4.12e-10 | 116 | 56 | 8 | CID000003878 | |
| Drug | APETx1, Anthopleura elegantissima | 4.90e-10 | 6 | 56 | 4 | ctd:C475726 | |
| Drug | N-(2-methyl-3-(4-(4-(4-(trifluoromethoxy)benzyloxy)piperidin-1-yl)-1,3,5-triazin-2-ylamino)phenyl)acetamide | 1.41e-08 | 3 | 56 | 3 | ctd:C561228 | |
| Drug | Tetrodotoxin | 4.62e-08 | 40 | 56 | 5 | ctd:D013779 | |
| Drug | Scorpion Venoms | 9.79e-08 | 18 | 56 | 4 | ctd:D012604 | |
| Drug | NSC7524 | 3.10e-07 | 182 | 56 | 7 | CID000005657 | |
| Drug | AC1NT1AF | 3.99e-07 | 25 | 56 | 4 | CID005322157 | |
| Drug | AC1L1MOZ | 5.52e-07 | 27 | 56 | 4 | CID000031958 | |
| Drug | bepridil | 6.60e-07 | 126 | 56 | 6 | CID000002351 | |
| Drug | 2,3,5,6-tetrafluoro-4-methylbenzyl (Z)-(1RS)-cis-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate | 7.82e-07 | 8 | 56 | 3 | ctd:C489827 | |
| Drug | tocainide | 8.57e-07 | 30 | 56 | 4 | CID000038945 | |
| Drug | phenytoin | 1.08e-06 | 219 | 56 | 7 | CID000001775 | |
| Drug | Sodium | 2.00e-06 | 84 | 56 | 5 | ctd:D012964 | |
| Drug | benzocaine | 2.04e-06 | 37 | 56 | 4 | CID000002337 | |
| Drug | gabapentin | 3.65e-06 | 169 | 56 | 6 | CID000003446 | |
| Drug | riluzole | 4.32e-06 | 174 | 56 | 6 | CID000005070 | |
| Drug | isradipine | 4.73e-06 | 100 | 56 | 5 | CID000003784 | |
| Drug | pilsicainide | 4.96e-06 | 46 | 56 | 4 | CID000004820 | |
| Drug | mu-conotoxin KIIIA, Conus kinoshitai | 5.94e-06 | 2 | 56 | 2 | ctd:C502265 | |
| Drug | Ranolazine | 5.94e-06 | 2 | 56 | 2 | DB00243 | |
| Drug | Phenytoin | 5.94e-06 | 2 | 56 | 2 | DB00252 | |
| Drug | Flecainide | 5.94e-06 | 2 | 56 | 2 | DB01195 | |
| Drug | Riluzole | 5.94e-06 | 2 | 56 | 2 | DB00740 | |
| Drug | tetradotoxin | 9.42e-06 | 428 | 56 | 8 | CID000020382 | |
| Drug | moricizine | 1.12e-05 | 18 | 56 | 3 | CID000034632 | |
| Drug | diprafenone | 1.33e-05 | 19 | 56 | 3 | CID000071249 | |
| Drug | methylglucamine | 1.65e-05 | 62 | 56 | 4 | CID000004049 | |
| Drug | mibefradil | 1.87e-05 | 64 | 56 | 4 | CID000060662 | |
| Drug | saxitoxin | 1.99e-05 | 65 | 56 | 4 | CID000037165 | |
| Drug | AC1L1CQC | 1.99e-05 | 65 | 56 | 4 | CID000002012 | |
| Drug | mexiletine | 2.11e-05 | 66 | 56 | 4 | CID000004178 | |
| Drug | disopyramide | 2.11e-05 | 66 | 56 | 4 | CID000003114 | |
| Drug | dibucaine | 2.38e-05 | 68 | 56 | 4 | CID000003025 | |
| Drug | verapamil | 2.49e-05 | 490 | 56 | 8 | CID000002520 | |
| Drug | flecainide | 2.82e-05 | 71 | 56 | 4 | CID000003355 | |
| Drug | decamethrin | 2.97e-05 | 146 | 56 | 5 | ctd:C017180 | |
| Drug | Multicide | 3.12e-05 | 25 | 56 | 3 | CID000024365 | |
| Drug | diphenhydramine | 3.50e-05 | 75 | 56 | 4 | CID000003100 | |
| Drug | Pirmenolum | 3.52e-05 | 26 | 56 | 3 | CID000004853 | |
| Drug | Fospropofol | 3.55e-05 | 4 | 56 | 2 | DB06716 | |
| Drug | Lidocaine | 3.55e-05 | 4 | 56 | 2 | DB00281 | |
| Drug | APETx2 protein, Anthopleura elegantissima | 3.55e-05 | 4 | 56 | 2 | ctd:C501880 | |
| Drug | Propofol | 3.55e-05 | 4 | 56 | 2 | DB00818 | |
| Drug | procaine | 3.72e-05 | 153 | 56 | 5 | CID000004914 | |
| Drug | PbTx-1 | 3.95e-05 | 27 | 56 | 3 | CID006437089 | |
| Drug | nefopam | 3.95e-05 | 27 | 56 | 3 | CID000004450 | |
| Drug | paraben | 4.42e-05 | 28 | 56 | 3 | CID000007175 | |
| Drug | encainide | 4.42e-05 | 28 | 56 | 3 | CID000048040 | |
| Drug | DPI 201-106 | 4.42e-05 | 28 | 56 | 3 | CID000005190 | |
| Drug | oxcarbazepine | 5.46e-05 | 30 | 56 | 3 | CID000034312 | |
| Drug | NSC93767 | 6.65e-05 | 32 | 56 | 3 | CID000005658 | |
| Drug | lomustine; Up 200; 100uM; PC3; HT_HG-U133A | 7.64e-05 | 178 | 56 | 5 | 7094_UP | |
| Drug | carbamazepine | 7.84e-05 | 179 | 56 | 5 | CID000002554 | |
| Drug | 5-hydroxypropafenone | 7.99e-05 | 34 | 56 | 3 | CID000107927 | |
| Drug | NSC15627 | 7.99e-05 | 34 | 56 | 3 | CID000002073 | |
| Drug | fenpropathrin | 8.86e-05 | 6 | 56 | 2 | ctd:C044267 | |
| Drug | si-wu-tang | 8.86e-05 | 6 | 56 | 2 | ctd:C403258 | |
| Drug | propafenone | 9.98e-05 | 98 | 56 | 4 | CID000004932 | |
| Drug | sipatrigine | 1.03e-04 | 37 | 56 | 3 | CID000060803 | |
| Drug | aprindine | 1.12e-04 | 38 | 56 | 3 | CID000002218 | |
| Drug | ranolazine | 1.21e-04 | 39 | 56 | 3 | CID000056959 | |
| Drug | methanethiosulfonate | 1.21e-04 | 103 | 56 | 4 | CID004188587 | |
| Drug | AC1NPPZW | 1.21e-04 | 103 | 56 | 4 | CID005183170 | |
| Drug | amiloride | 1.21e-04 | 315 | 56 | 6 | CID000016230 | |
| Drug | Flumequine [42835-25-6]; Down 200; 15.4uM; HL60; HG-U133A | 1.23e-04 | 197 | 56 | 5 | 1429_DN | |
| Drug | fluorocyclobutane | 1.24e-04 | 7 | 56 | 2 | CID011051569 | |
| Drug | 1,2-dihydroxynaphthalene | 1.24e-04 | 7 | 56 | 2 | ctd:C050642 | |
| Drug | S-ropivacaine | 1.31e-04 | 40 | 56 | 3 | CID000071273 | |
| Drug | pyraclofos | 1.35e-04 | 106 | 56 | 4 | CID000093460 | |
| Drug | potassium | SCN2A SCN3A SCN4A SCN5A SCN9A TMEM37 CATSPER3 TAC3 PKD1L3 SLC7A11 | 1.54e-04 | 1008 | 56 | 10 | CID000000813 |
| Drug | spiradoline | 1.98e-04 | 46 | 56 | 3 | CID000005620 | |
| Drug | Mexiletine | 2.12e-04 | 9 | 56 | 2 | ctd:D008801 | |
| Drug | indoxacarb | 2.40e-04 | 49 | 56 | 3 | CID000107720 | |
| Drug | pimozide | 2.71e-04 | 127 | 56 | 4 | CID000016362 | |
| Drug | Nicorette | 3.04e-04 | 529 | 56 | 7 | CID000000942 | |
| Drug | AC1NSN3X | 3.20e-04 | 54 | 56 | 3 | CID005366189 | |
| Drug | RH-3421 | 3.22e-04 | 11 | 56 | 2 | CID000108039 | |
| Drug | chloroacetylajmaline | 3.22e-04 | 11 | 56 | 2 | CID000038681 | |
| Drug | 4-hydroxyestrone | 3.86e-04 | 12 | 56 | 2 | ctd:C026418 | |
| Drug | Ro 22-9194 | 3.86e-04 | 12 | 56 | 2 | CID000129209 | |
| Drug | triamterene | 3.95e-04 | 58 | 56 | 3 | CID000005546 | |
| Drug | CID6432355 | 4.55e-04 | 13 | 56 | 2 | CID006432355 | |
| Drug | 20(S)-Propanaxidiol | 4.55e-04 | 13 | 56 | 2 | CID005317623 | |
| Drug | AC1LCJM3 | 4.55e-04 | 13 | 56 | 2 | CID000631640 | |
| Drug | zonisamide | 4.81e-04 | 62 | 56 | 3 | CID000005734 | |
| Drug | dofetilide | 5.04e-04 | 63 | 56 | 3 | CID000071329 | |
| Drug | lorcainide | 5.31e-04 | 14 | 56 | 2 | CID000042883 | |
| Drug | octylguanidine | 5.31e-04 | 14 | 56 | 2 | CID000030621 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 7.18e-18 | 10 | 56 | 7 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 7.18e-18 | 10 | 56 | 7 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 4.72e-17 | 12 | 56 | 7 | DOID:0060170 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 2.55e-08 | 163 | 56 | 7 | DOID:1826 (implicated_via_orthology) | |
| Disease | anxiety disorder (implicated_via_orthology) | 8.29e-08 | 22 | 56 | 4 | DOID:2030 (implicated_via_orthology) | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 5.39e-07 | 9 | 56 | 3 | C3502809 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 1.83e-06 | 13 | 56 | 3 | C0751122 | |
| Disease | Early Infantile Epileptic Encephalopathy 6 | 3.54e-06 | 2 | 56 | 2 | C4551549 | |
| Disease | B Virus Infection | 1.06e-05 | 3 | 56 | 2 | C0037140 | |
| Disease | Benign familial infantile epilepsy | 1.06e-05 | 3 | 56 | 2 | cv:C5575231 | |
| Disease | Postherpetic neuralgia | 1.06e-05 | 3 | 56 | 2 | C0032768 | |
| Disease | Herpesviridae Infections | 1.06e-05 | 3 | 56 | 2 | C0019372 | |
| Disease | Familial benign neonatal epilepsy | 5.28e-05 | 6 | 56 | 2 | C0220669 | |
| Disease | Epilepsy | 5.58e-05 | 109 | 56 | 4 | C0014544 | |
| Disease | Seizure, Febrile, Simple | 7.38e-05 | 7 | 56 | 2 | C0149886 | |
| Disease | Seizure, Febrile, Complex | 7.38e-05 | 7 | 56 | 2 | C0751057 | |
| Disease | Early Childhood Epilepsy, Myoclonic | 9.83e-05 | 8 | 56 | 2 | C0393695 | |
| Disease | Idiopathic Myoclonic Epilepsy | 9.83e-05 | 8 | 56 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 9.83e-05 | 8 | 56 | 2 | C0338479 | |
| Disease | Myoclonic Encephalopathy | 9.83e-05 | 8 | 56 | 2 | C0438414 | |
| Disease | Benign Infantile Myoclonic Epilepsy | 9.83e-05 | 8 | 56 | 2 | C0751120 | |
| Disease | Myoclonic Absence Epilepsy | 9.83e-05 | 8 | 56 | 2 | C0393703 | |
| Disease | Febrile Convulsions | 1.26e-04 | 9 | 56 | 2 | C0009952 | |
| Disease | Myoclonic Epilepsy | 1.26e-04 | 9 | 56 | 2 | C0014550 | |
| Disease | Epilepsy, Myoclonic, Infantile | 1.58e-04 | 10 | 56 | 2 | C0917800 | |
| Disease | Myoclonic Astatic Epilepsy | 1.92e-04 | 11 | 56 | 2 | C0393702 | |
| Disease | MMR-related febrile seizures | 3.66e-04 | 15 | 56 | 2 | EFO_0006519 | |
| Disease | Hypogonadotropic hypogonadism | 3.66e-04 | 15 | 56 | 2 | C0271623 | |
| Disease | Primary hypogonadism | 3.66e-04 | 15 | 56 | 2 | C0948896 | |
| Disease | Hypogonadism, Isolated Hypogonadotropic | 3.66e-04 | 15 | 56 | 2 | C3489396 | |
| Disease | Hypogonadism | 4.17e-04 | 16 | 56 | 2 | C0020619 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 4.17e-04 | 16 | 56 | 2 | C0393706 | |
| Disease | Epilepsy, Cryptogenic | 5.16e-04 | 82 | 56 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 5.16e-04 | 82 | 56 | 3 | C0751111 | |
| Disease | Aura | 5.16e-04 | 82 | 56 | 3 | C0236018 | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 5.31e-04 | 18 | 56 | 2 | HP_0002373 | |
| Disease | Idiopathic hypogonadotropic hypogonadism | 5.31e-04 | 18 | 56 | 2 | C0342384 | |
| Disease | Neurodevelopmental Disorders | 7.44e-04 | 93 | 56 | 3 | C1535926 | |
| Disease | gamma-linolenic acid measurement | 9.51e-04 | 24 | 56 | 2 | EFO_0007762 | |
| Disease | congestive heart failure (biomarker_via_orthology) | 1.12e-03 | 107 | 56 | 3 | DOID:6000 (biomarker_via_orthology) | |
| Disease | chronic kidney disease (biomarker_via_orthology) | 1.30e-03 | 28 | 56 | 2 | DOID:784 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ALRNTSNFFLVSLFT | 56 | P50406 | |
| GNLAAAFFTLFSLAT | 211 | Q86XQ3 | |
| NSFLASIIFSNSLFD | 3456 | Q86UQ4 | |
| ASFSAEDLSLFLSTR | 51 | Q6ZUJ8 | |
| LAALFFFSLSSSLLY | 16 | O43286 | |
| FTASFLLFLNAISGL | 166 | Q8WXS4 | |
| TQSFLLSAFFSRANL | 641 | Q8IZY2 | |
| TATDAASLFALQAFL | 591 | Q7Z401 | |
| AFFSVITSILLDSSF | 556 | Q9HCM3 | |
| FLSTLLDSFSSSRVF | 616 | O94822 | |
| AVISNAFLLAFSSDF | 776 | Q6IWH7 | |
| SSLLSFAELFSFMLQ | 381 | Q96JP0 | |
| NLALADFSFTATLPF | 66 | P25090 | |
| RFFSSALASLTLDTS | 246 | P57737 | |
| TSSQDVEFLLFALFS | 21 | Q8NGC6 | |
| FLNAFEDSFSSILST | 246 | Q16236 | |
| LSLALSDFLFLAAAA | 71 | Q8TDT2 | |
| FFLFNLSLVDTLLSS | 61 | O60431 | |
| FFLSNLSSLDLAFAT | 61 | O95371 | |
| DLHLLFNLISSSSSF | 441 | Q86VX9 | |
| FFLSNLSFADLCFTS | 61 | O76099 | |
| VTFFLFLLSATFNAS | 41 | P30968 | |
| FLLSATFNASFLLKL | 46 | P30968 | |
| SNRSLLAFIFFFSLS | 11 | Q9UBX8 | |
| TFLLEFEFSCSSLLS | 891 | O75578 | |
| FIDSLFNLDSKSSSF | 916 | Q9Y4D2 | |
| SANTRFALDLFLALS | 6 | P30740 | |
| SLASVSVAFLFSLFL | 176 | Q9BZV2 | |
| FTALAASTFSLLFTA | 126 | O95977 | |
| LFLSNLSFSDLCFSS | 61 | P47887 | |
| FLLANLSLVDIFFSS | 61 | Q9P1Q5 | |
| LFLSNLSFSDLCFSS | 61 | P30953 | |
| FFLSNLSLLDICFTT | 61 | Q8NGZ4 | |
| LFLALLLSSFSADSL | 796 | P35499 | |
| HNSCISALFLLFFSA | 701 | Q96NR3 | |
| FFLSNLSFLDICLST | 61 | Q8NG99 | |
| AREALFALSSNLSFL | 86 | Q9NPR2 | |
| LASAFFTALYSLELS | 1166 | Q7Z443 | |
| LNLFLALLLSSFSAD | 931 | Q14524 | |
| NLFLALLLSSFSSDN | 961 | Q15858 | |
| ASSRDFFSSLQPLFA | 171 | Q9NVD3 | |
| DFCSLFSSNSNLKFL | 666 | Q8WX94 | |
| LNLFLALLLSSFSSD | 976 | Q9NY46 | |
| ALLLSFELRNFSSLS | 411 | Q9P2P6 | |
| DNIFFSSLSLLYALS | 26 | Q96P15 | |
| KALLSSLNDFASLSF | 31 | Q9GZT8 | |
| FLFTAVSLLSLFLSA | 166 | Q9NPE6 | |
| LFLALLLSSFSADNL | 986 | P35498 | |
| DSNGLFLFSSFALTL | 256 | Q9NWW5 | |
| FSGDLDSLLNFLSFA | 381 | Q9UPY5 | |
| IFDEFFSSSALNALA | 1061 | Q5W0Q7 | |
| RASSSTFFFQLVLLL | 526 | Q8IU68 | |
| NLFLALLLSSFSSDN | 976 | Q99250 | |
| LFLALLLSSFSADNL | 971 | Q9UQD0 | |
| GNVFFSSLSLFAALA | 26 | O75635 | |
| SSGLLFATFLLLSLF | 176 | Q96GR4 | |
| FATFLLLSLFSLVAS | 181 | Q96GR4 | |
| LFTAILAFSLAQSFG | 6 | Q9UHF0 | |
| FSLLTSSSNGIFDLF | 106 | Q9HAW7 |